Adage Capital Partners Gp, L.L.C. Kodiak Sciences Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,325,707 shares of KOD stock, worth $10.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,325,707
Previous 1,139,527
16.34%
Holding current value
$10.5 Million
Previous $11.3 Million
67.15%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding KOD
# of Institutions
110Shares Held
41.7MCall Options Held
10.9KPut Options Held
700-
Baker Bros. Advisors LP New York, NY17.3MShares$137 Million0.58% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$30.4 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$15.6 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.82MShares$14.4 Million0.0% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.27MShares$10 Million0.09% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $411M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...